335 related articles for article (PubMed ID: 23335611)
1. Assessment of impaired glucose tolerance prevalence with hemoglobin A₁c and oral glucose tolerance test in 252 Turkish women with polycystic ovary syndrome: a prospective, controlled study.
Celik C; Abali R; Bastu E; Tasdemir N; Tasdemir UG; Gul A
Hum Reprod; 2013 Apr; 28(4):1062-8. PubMed ID: 23335611
[TBL] [Abstract][Full Text] [Related]
2. Assessment of glucose metabolism in polycystic ovary syndrome: HbA1c or fasting glucose compared with the oral glucose tolerance test as a screening method.
Lerchbaum E; Schwetz V; Giuliani A; Obermayer-Pietsch B
Hum Reprod; 2013 Sep; 28(9):2537-44. PubMed ID: 23756702
[TBL] [Abstract][Full Text] [Related]
3. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
Yildiz BO; Yarali H; Oguz H; Bayraktar M
J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
[TBL] [Abstract][Full Text] [Related]
4. Assessment of insulin resistance and impaired glucose tolerance in lean women with polycystic ovary syndrome.
Stovall DW; Bailey AP; Pastore LM
J Womens Health (Larchmt); 2011 Jan; 20(1):37-43. PubMed ID: 21194310
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.
Ehrmann DA; Barnes RB; Rosenfield RL; Cavaghan MK; Imperial J
Diabetes Care; 1999 Jan; 22(1):141-6. PubMed ID: 10333916
[TBL] [Abstract][Full Text] [Related]
6. Overweight and obese but not normal weight women with PCOS are at increased risk of Type 2 diabetes mellitus-a prospective, population-based cohort study.
Ollila MM; West S; Keinänen-Kiukaanniemi S; Jokelainen J; Auvinen J; Puukka K; Ruokonen A; Järvelin MR; Tapanainen JS; Franks S; Piltonen TT; Morin-Papunen LC
Hum Reprod; 2017 Feb; 32(2):423-431. PubMed ID: 28031324
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and possible mechanisms of reactive hypoglycemia in polycystic ovary syndrome.
Mumm H; Altinok ML; Henriksen JE; Ravn P; Glintborg D; Andersen M
Hum Reprod; 2016 May; 31(5):1105-12. PubMed ID: 27008892
[TBL] [Abstract][Full Text] [Related]
8. Dysglycemia screening with oral glucose tolerance test in adolescents with polycystic ovary syndrome and relationship with obesity.
Gupta J; Antal Z; Mauer E; Gerber LM; An A; Censani M
BMC Endocr Disord; 2022 Jul; 22(1):180. PubMed ID: 35842601
[TBL] [Abstract][Full Text] [Related]
9. Association of severity of menstrual dysfunction with hyperinsulinemia and dysglycemia in polycystic ovary syndrome.
Ezeh U; Pisarska MD; Azziz R
Hum Reprod; 2022 Mar; 37(3):553-564. PubMed ID: 35048126
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of Type 2 diabetes is not increased in normal-weight women with PCOS.
Pelanis R; Mellembakken JR; Sundström-Poromaa I; Ravn P; Morin-Papunen L; Tapanainen JS; Piltonen T; Puurunen J; Hirschberg AL; Fedorcsak P; Andersen M; Glintborg D
Hum Reprod; 2017 Nov; 32(11):2279-2286. PubMed ID: 29040530
[TBL] [Abstract][Full Text] [Related]
11. Fasting glucose measurement as a potential first step screening for glucose metabolism abnormalities in women with anovulatory polycystic ovary syndrome.
Veltman-Verhulst SM; Goverde AJ; van Haeften TW; Fauser BC
Hum Reprod; 2013 Aug; 28(8):2228-34. PubMed ID: 23739218
[TBL] [Abstract][Full Text] [Related]
12. Prolactin is associated with metabolic risk and cortisol in 1007 women with polycystic ovary syndrome.
Glintborg D; Altinok M; Mumm H; Buch K; Ravn P; Andersen M
Hum Reprod; 2014 Aug; 29(8):1773-9. PubMed ID: 24903198
[TBL] [Abstract][Full Text] [Related]
13. Diagnosing dysglycemia in adolescents with polycystic ovary syndrome.
Gooding HC; Milliren C; St Paul M; Mansfield MJ; DiVasta A
J Adolesc Health; 2014 Jul; 55(1):79-84. PubMed ID: 24560306
[TBL] [Abstract][Full Text] [Related]
14. The prevalence and risk factors for glucose intolerance in young Korean women with polycystic ovary syndrome.
Lee H; Oh JY; Sung YA; Chung H; Cho WY
Endocrine; 2009 Oct; 36(2):326-32. PubMed ID: 19688613
[TBL] [Abstract][Full Text] [Related]
15. Polycystic ovary syndrome in adolescence: impaired glucose tolerance occurs across the spectrum of BMI.
Flannery CA; Rackow B; Cong X; Duran E; Selen DJ; Burgert TS
Pediatr Diabetes; 2013 Feb; 14(1):42-9. PubMed ID: 22925367
[TBL] [Abstract][Full Text] [Related]
16. Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome.
Macut D; Tziomalos K; Božić-Antić I; Bjekić-Macut J; Katsikis I; Papadakis E; Andrić Z; Panidis D
Hum Reprod; 2016 Jun; 31(6):1347-53. PubMed ID: 27076501
[TBL] [Abstract][Full Text] [Related]
17. Oral glucose tolerance test significantly impacts the prevalence of abnormal glucose tolerance among Indian women with polycystic ovary syndrome: lessons from a large database of two tertiary care centers on the Indian subcontinent.
Ganie MA; Dhingra A; Nisar S; Sreenivas V; Shah ZA; Rashid A; Masoodi S; Gupta N
Fertil Steril; 2016 Jan; 105(1):194-201.e1-3. PubMed ID: 26407537
[TBL] [Abstract][Full Text] [Related]
18. Abnormal glucose tolerance in Chinese women with polycystic ovary syndrome.
Chen X; Yang D; Li L; Feng S; Wang L
Hum Reprod; 2006 Aug; 21(8):2027-32. PubMed ID: 16684838
[TBL] [Abstract][Full Text] [Related]
19. Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study.
Celik C; Tasdemir N; Abali R; Bastu E; Yilmaz M
Fertil Steril; 2014 Apr; 101(4):1123-8.e1. PubMed ID: 24502891
[TBL] [Abstract][Full Text] [Related]
20. Screening for dysglycaemia by oral glucose tolerance test should be recommended in all women with polycystic ovary syndrome.
Li HW; Lam KS; Tam S; Lee VC; Yeung TW; Cheung PT; Yeung WS; Ho PC; Ng EH
Hum Reprod; 2015 Sep; 30(9):2178-83. PubMed ID: 26202923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
